Miriam is a bioinformatics expert at Achilles Therapeutics, where she has held roles including Director and Specialist. Her work focuses on the design and delivery of the PELEUS™ bioinformatics platform, which is crucial for developing personalized T-cell therapies for lung cancer and melanoma. She holds a Ph. D. from Imperial College London.
Her work is central to producing clonal neoantigen-targeting T-cell therapies for Phase I/II clinical trials.
Read the full overview →Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.
Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.
Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.